Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) targeting inflammatory diseases and oncology. Its structure enables selective binding to specific enzyme sites, enhancing drug efficacy. Commonly utilized in research and development of small-molecule therapeutics due to its favorable reactivity and stability in multi-step organic synthesis.